Going beyond protein degradation, a new Broad startup kicks into gear to fix protein functionality

08 Sep 2022

There’s a plethora of protein degradation biotechs, and a smaller handful of protein stabilization players, but Lizzie Ngo was searching for something more. The principal at Longwood Fund, the investment firm behind the likes of Bicycle Therapeutics, wanted to know, “What else could we do beyond just targeted protein degradation?” she told Endpoints News . While mapping out the space, she and a colleague came across a 2020 paper from Amit Choudhary’s lab at MIT and Harvard’s Broad Institute. As so many biotechs’ origin stories begin, the paper led to a new startup with ambitions going beyond protein degradation and stabilization and into activation, inactivation and trafficking of proteins.

For more details,please visit the original website

The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.

Organizations

Zhongshan Broad-Ocean Motor Co., Ltd.

Longwood Gardens, Inc.

Harvard Business School

[+1]

Indications

Targets

Drugs

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.